Find

  • All tenders
Germany: Tenders/Universitätsklinikum Bonn AöR/Toxicology and Safety Pharmacology Study

Toxicology and Safety Pharmacology Study

Expired

The competition has expired without a winner being announced.

Deadline
Mar 4,Expired
Procedure
OpenSingle stage
Agreement
Buying services

Brief

Universitätsklinikum Bonn AöR needs toxicology and safety pharmacology studies, including GLP in vitro and in vivo studies, for an anti-parasitic drug of DNDi.

Forsknings- og analyselaboratorier

Register interest

Previous winners

  • Who are you up against?

    The suppliers who have won similar contracts at Universitätsklinikum Bonn AöR

Will you bid?

The agent sets up the bid and writes the first draft. Free for 14 days.

Qualification requirements

  • Description

    Leverandøren skal være registrert i et offentlig register (f.eks. handelsregister).

    Documentation Requirement

    Sertifikat: Bevis på registrering i et offentlig register (f.eks. handels- eller sentralregister; ikke eldre enn tre måneder) eller tilsvarende.

    Source

    No source found in the documents. Check the requirement against the tender documents.

From the notice

  • The procurement, published by means of the contract notice in the relevant world-wide publications, concerns the conduct of a toxicology and safety pharmacology studies, GLP in vitro and in vivo study for an anti-parasitic drug of DNDi.

  • Contact

    GB4-Abteilung Einkaufeinkauf@ukbonn.de
  • Type
    Competition
  • Main code
    Research and development services and related consultancy services
    73000000
  • 71900000Laboratory services73111000Research laboratory services85145000Services provided by medical laboratories

Similar active competitions

  • Helmholtz-Zentrum für Infektionsforschung GmbH

    Forsknings- og utviklingsvirksomhet og tilhørende konsulenttjenester

    Non-Clinical Toxicology and safety assessment of a small molecule

    Helmholtz-Zentrum für Infektionsforschung GmbH seeks services under a framework agreement to conduct a nonclinical toxicology and safety assessment programme for a small-molecule drug candidate, with delivery in Braunschweig, Germany. The work includes assessing safety after intravenous infusion, with particular focus on renal function and toxicity, and a dermal toxicology programme to support a potential topical semisolid formulation; the dermal work is subject to a Go/No-Go decision. The programme must meet applicable regulatory requirements and produce documentation suitable for submissions in the EU and US, supporting first-in-human trials and further clinical development. The project manager must have C1-level German or English, and applicable studies must comply with OECD GLP or equivalent principles, supported by GLP compliance evidence. Evaluation gives 75% weight to quality (project execution concept 45%, capability concept 30%) and 25% to price.

    Framework agreement
    Dec 7, 2026(14 days)
  • European Medicines Agency

    Forskning og miljøovervåking

    Open call for scientific and regulatory experts

    The European Medicines Agency needs scientific and regulatory experts for a 5-year period to provide advice on scientific, regulatory, and training activities related to medicines for human use and veterinary medicinal products. The services will support the Agency within the scope of Article 57(1) of Regulation (EC) No 726/2004 and Regulation (EU) 2022/123, as provided in Article 242 of Regulation (EU, Euratom) 2024/2509 (EU Financial Regulation).

    Competition
    Dec 31, 2030(100+ days)
  • Charité - Universitätsmedizin Berlin

    CRO PENELOPE-Studie

    Die Charité – Universitätsmedizin Berlin sucht im Rahmen eines Dienstleistungsauftrags ein Auftragsforschungsinstitut (CRO) zur Durchführung der PENELOPE-Studie in Berlin über 6 Jahre. Gesucht werden CRO-Leistungen mit Schwerpunkt auf investigator-initiierten Studien (IITs) in der thorakalen Onkologie; vergleichbare Leistungen umfassen interventionelle, randomisierte Studien mit jeweils mindestens 80 Teilnehmenden und einer Laufzeit von mindestens 3 Jahren. Für die Eignung sind drei vergleichbare Unternehmensreferenzen aus den letzten fünf Jahren erforderlich. Bewertet werden Preis (30 %), Qualifikation und Erfahrung der Projektleitung (35 %) sowie das Umsetzungskonzept (35 %).

    Framework agreement
    Dec 3, 2026(10 days)